Specifically, subsets of NSCLC with specific genetic alterations have been identified, including those that harbor abnormalities in EGFR, ALK, MET, HER2, ROS1, BRAF, RET, NTRK1, PIK3CA, KRAS, and MEK [3]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.